Search
for
Sort by
Research 241–270 of 1000+
- 032 A multicomponent skin-targeted COVID-19 vaccine elicits robust humoral and cellular immune responses
- Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19
- MAIT Cells in COVID-19: Heroes, Villains, or Both?
- New insights into alopecia areata during COVID‐19 pandemic: When infection or vaccination could play a role
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Manifestações dermatológicas durante e após a COVID-19: Uma revisão narrativa / Dermatological manifestations during and after Covid-19: A narrative review
- Severe Acute Respiratory Syndrome (SARS)
- Unraveling the mechanism of action of cepharanthine for the treatment of novel coronavirus pneumonia (COVID-19) from the perspectives of systematic pharmacology
- A Rapidly Progressive Case of Skin and Soft Tissues Necrosis in a COVID-19 Positive Patient
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients
- Long-COVID symptoms after multisystem inflammatory syndrome in children during different pandemic waves
- Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review
- Pharmacological Activity of Cepharanthine
- A clinical case of a patient with mucocutaneous and musculoskeletal manifestations after COVID-19 vaccination
- Clinical diagnosis of COVID-19: a prompt, feasible, and sensitive diagnostic tool for COVID-19 based on a 1,757-patient cohort (The AndroCoV Clinical Scoring for COVID-19 diagnosis)
- Relationship Between the Route of Transmission, Environmental Tolerance and Mutation Rate of Some RNA Viruses with Their Pathogenicity
- Updated Integrated Safety Analysis of Ritlecitinib up to ~5 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials
- 220 Dynamic and spatial transcriptional responses in COVID-19-related chilblains
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Clinical diagnosis of COVID-19: a prompt, feasible, and sensitive diagnostic tool for COVID-19 based on a 1,757-patient cohort (The AndroCoV Clinical Scoring for COVID-19 diagnosis).
- Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment
- Post-COVID Telogen Effluvium.
- More than 50 long-term effects of COVID-19: a systematic review and meta-analysis
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- The AndroCoV Clinical Scoring for COVID-19 Diagnosis: A Prompt, Feasible, Costless, and Highly Sensitive Diagnostic Tool for COVID-19 Based on a 1757-Patient Cohort
- Is there a POST‐COVID dermatological syndrome? The integrated dermato‐infectious disease experience of a single centre
- Severe Acute Respiratory Syndrome Among Children